Gastrointestinal Stromal Tumor (GIST) Drug Market Report

Global and Region Gastrointestinal Stromal Tumor (GIST) Drug Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：235
  • REPORT CODE：GMM906740
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Gastrointestinal Stromal Tumor (GIST) Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Gastrointestinal Stromal Tumor (GIST) Drugmarket, defines the market attractiveness level of Gastrointestinal Stromal Tumor (GIST) Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Gastrointestinal Stromal Tumor (GIST) Drug industry, describes the types of Gastrointestinal Stromal Tumor (GIST) Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Gastrointestinal Stromal Tumor (GIST) Drug market and the development prospects and opportunities of Gastrointestinal Stromal Tumor (GIST) Drug industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Gastrointestinal Stromal Tumor (GIST) Drug market in Chapter 13.

    By Player:

    • Kolltan Pharmaceuticals, Inc

    • Omeros Corporation

    • Arog Pharmaceuticals, Inc

    • Jiangsu Hengrui Medicine Co, Ltd

    • F Hoffmann-La Roche Ltd

    • Chipscreen Biosciences Ltd

    • Astex Pharmaceuticals, Inc

    • Natco Pharma Limited

    • Immunicum AB

    • Blueprint Medicines Corporation

    • Ariad Pharmaceuticals, Inc

    • Nerviano Medical Sciences Srl

    • Array BioPharma Inc

    • Horizon Pharma Plc

    • Boston Biomedical, Inc

    • Calithera Biosciences, Inc

    • Deciphera Pharmaceuticals, LLC

    • Novartis AG

    By Type:

    • Amcasertib

    • Anagrelide hydrochloride CR

    • APG-1351

    • Binimetinib

    • Others

    By End-User:

    • Clinic

    • Hospital

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Gastrointestinal Stromal Tumor (GIST) Drug Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Gastrointestinal Stromal Tumor (GIST) Drug Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Gastrointestinal Stromal Tumor (GIST) Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Gastrointestinal Stromal Tumor (GIST) Drug Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Gastrointestinal Stromal Tumor (GIST) Drug Market Analysis and Outlook to 2022

    • 7.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption (2017-2022)

    • 7.2 United States Gastrointestinal Stromal Tumor (GIST) Drug Consumption (2017-2022)

    • 7.3 Europe Gastrointestinal Stromal Tumor (GIST) Drug Consumption (2017-2022)

    • 7.4 China Gastrointestinal Stromal Tumor (GIST) Drug Consumption (2017-2022)

    • 7.5 Japan Gastrointestinal Stromal Tumor (GIST) Drug Consumption (2017-2022)

    • 7.6 India Gastrointestinal Stromal Tumor (GIST) Drug Consumption (2017-2022)

    • 7.7 South Korea Gastrointestinal Stromal Tumor (GIST) Drug Consumption (2017-2022)

    8 Region and Country-wise Gastrointestinal Stromal Tumor (GIST) Drug Market Analysis and Outlook to 2028

    • 8.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast (2022-2028)

    • 8.2 United States Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast (2022-2028)

    • 8.3 Europe Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast (2022-2028)

    • 8.4 China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast (2022-2028)

    • 8.5 Japan Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast (2022-2028)

    • 8.6 India Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast (2022-2028)

    • 8.7 South Korea Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast (2022-2028)

    9 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Outlook by Types and Applications to 2022

    • 9.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Amcasertib Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Anagrelide hydrochloride CR Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global APG-1351 Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Binimetinib Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Clinic Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Outlook by Types and Applications to 2028

    • 10.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Amcasertib Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Anagrelide hydrochloride CR Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global APG-1351 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Binimetinib Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Clinic Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Gastrointestinal Stromal Tumor (GIST) Drug Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Gastrointestinal Stromal Tumor (GIST) Drug Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Competitive Analysis

    • 14.1 Kolltan Pharmaceuticals, Inc

      • 14.1.1 Kolltan Pharmaceuticals, Inc Company Details

      • 14.1.2 Kolltan Pharmaceuticals, Inc Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Kolltan Pharmaceuticals, Inc Gastrointestinal Stromal Tumor (GIST) Drug Product and Service

    • 14.2 Omeros Corporation

      • 14.2.1 Omeros Corporation Company Details

      • 14.2.2 Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product and Service

    • 14.3 Arog Pharmaceuticals, Inc

      • 14.3.1 Arog Pharmaceuticals, Inc Company Details

      • 14.3.2 Arog Pharmaceuticals, Inc Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Arog Pharmaceuticals, Inc Gastrointestinal Stromal Tumor (GIST) Drug Product and Service

    • 14.4 Jiangsu Hengrui Medicine Co, Ltd

      • 14.4.1 Jiangsu Hengrui Medicine Co, Ltd Company Details

      • 14.4.2 Jiangsu Hengrui Medicine Co, Ltd Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Jiangsu Hengrui Medicine Co, Ltd Gastrointestinal Stromal Tumor (GIST) Drug Product and Service

    • 14.5 F Hoffmann-La Roche Ltd

      • 14.5.1 F Hoffmann-La Roche Ltd Company Details

      • 14.5.2 F Hoffmann-La Roche Ltd Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 F Hoffmann-La Roche Ltd Gastrointestinal Stromal Tumor (GIST) Drug Product and Service

    • 14.6 Chipscreen Biosciences Ltd

      • 14.6.1 Chipscreen Biosciences Ltd Company Details

      • 14.6.2 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Product and Service

    • 14.7 Astex Pharmaceuticals, Inc

      • 14.7.1 Astex Pharmaceuticals, Inc Company Details

      • 14.7.2 Astex Pharmaceuticals, Inc Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Astex Pharmaceuticals, Inc Gastrointestinal Stromal Tumor (GIST) Drug Product and Service

    • 14.8 Natco Pharma Limited

      • 14.8.1 Natco Pharma Limited Company Details

      • 14.8.2 Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Product and Service

    • 14.9 Immunicum AB

      • 14.9.1 Immunicum AB Company Details

      • 14.9.2 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Product and Service

    • 14.10 Blueprint Medicines Corporation

      • 14.10.1 Blueprint Medicines Corporation Company Details

      • 14.10.2 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product and Service

    • 14.11 Ariad Pharmaceuticals, Inc

      • 14.11.1 Ariad Pharmaceuticals, Inc Company Details

      • 14.11.2 Ariad Pharmaceuticals, Inc Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Ariad Pharmaceuticals, Inc Gastrointestinal Stromal Tumor (GIST) Drug Product and Service

    • 14.12 Nerviano Medical Sciences Srl

      • 14.12.1 Nerviano Medical Sciences Srl Company Details

      • 14.12.2 Nerviano Medical Sciences Srl Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Nerviano Medical Sciences Srl Gastrointestinal Stromal Tumor (GIST) Drug Product and Service

    • 14.13 Array BioPharma Inc

      • 14.13.1 Array BioPharma Inc Company Details

      • 14.13.2 Array BioPharma Inc Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Array BioPharma Inc Gastrointestinal Stromal Tumor (GIST) Drug Product and Service

    • 14.14 Horizon Pharma Plc

      • 14.14.1 Horizon Pharma Plc Company Details

      • 14.14.2 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Product and Service

    • 14.15 Boston Biomedical, Inc

      • 14.15.1 Boston Biomedical, Inc Company Details

      • 14.15.2 Boston Biomedical, Inc Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Boston Biomedical, Inc Gastrointestinal Stromal Tumor (GIST) Drug Product and Service

    • 14.16 Calithera Biosciences, Inc

      • 14.16.1 Calithera Biosciences, Inc Company Details

      • 14.16.2 Calithera Biosciences, Inc Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Calithera Biosciences, Inc Gastrointestinal Stromal Tumor (GIST) Drug Product and Service

    • 14.17 Deciphera Pharmaceuticals, LLC

      • 14.17.1 Deciphera Pharmaceuticals, LLC Company Details

      • 14.17.2 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Product and Service

    • 14.18 Novartis AG

      • 14.18.1 Novartis AG Company Details

      • 14.18.2 Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Gastrointestinal Stromal Tumor (GIST) Drug

    • Figure Gastrointestinal Stromal Tumor (GIST) Drug Picture

    • Table Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Country (2017-2022)

    • Figure United States Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2017-2022)

    • Table Europe Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2017-2022)

    • Figure China Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2017-2022)

    • Figure Japan Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2017-2022)

    • Figure India Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2017-2022)

    • Figure South Korea Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2017-2022)

    • Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast by Country (2022-2028)

    • Figure United States Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Amcasertib Consumption and Growth Rate (2017-2022)

    • Figure Global Anagrelide hydrochloride CR Consumption and Growth Rate (2017-2022)

    • Figure Global APG-1351 Consumption and Growth Rate (2017-2022)

    • Figure Global Binimetinib Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Clinic Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Amcasertib Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Anagrelide hydrochloride CR Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global APG-1351 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Binimetinib Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Gastrointestinal Stromal Tumor (GIST) Drug Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Gastrointestinal Stromal Tumor (GIST) Drug Export by Region (Top 5 Countries) (2017-2028)

    • Table Kolltan Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)

    • Table Kolltan Pharmaceuticals, Inc Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Kolltan Pharmaceuticals, Inc Gastrointestinal Stromal Tumor (GIST) Drug Product and Service

    • Table Omeros Corporation (Foundation Year, Company Profile and etc.)

    • Table Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product and Service

    • Table Arog Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)

    • Table Arog Pharmaceuticals, Inc Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Arog Pharmaceuticals, Inc Gastrointestinal Stromal Tumor (GIST) Drug Product and Service

    • Table Jiangsu Hengrui Medicine Co, Ltd (Foundation Year, Company Profile and etc.)

    • Table Jiangsu Hengrui Medicine Co, Ltd Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Jiangsu Hengrui Medicine Co, Ltd Gastrointestinal Stromal Tumor (GIST) Drug Product and Service

    • Table F Hoffmann-La Roche Ltd (Foundation Year, Company Profile and etc.)

    • Table F Hoffmann-La Roche Ltd Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table F Hoffmann-La Roche Ltd Gastrointestinal Stromal Tumor (GIST) Drug Product and Service

    • Table Chipscreen Biosciences Ltd (Foundation Year, Company Profile and etc.)

    • Table Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Product and Service

    • Table Astex Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)

    • Table Astex Pharmaceuticals, Inc Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astex Pharmaceuticals, Inc Gastrointestinal Stromal Tumor (GIST) Drug Product and Service

    • Table Natco Pharma Limited (Foundation Year, Company Profile and etc.)

    • Table Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Product and Service

    • Table Immunicum AB (Foundation Year, Company Profile and etc.)

    • Table Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Product and Service

    • Table Blueprint Medicines Corporation (Foundation Year, Company Profile and etc.)

    • Table Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product and Service

    • Table Ariad Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)

    • Table Ariad Pharmaceuticals, Inc Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ariad Pharmaceuticals, Inc Gastrointestinal Stromal Tumor (GIST) Drug Product and Service

    • Table Nerviano Medical Sciences Srl (Foundation Year, Company Profile and etc.)

    • Table Nerviano Medical Sciences Srl Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nerviano Medical Sciences Srl Gastrointestinal Stromal Tumor (GIST) Drug Product and Service

    • Table Array BioPharma Inc (Foundation Year, Company Profile and etc.)

    • Table Array BioPharma Inc Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Array BioPharma Inc Gastrointestinal Stromal Tumor (GIST) Drug Product and Service

    • Table Horizon Pharma Plc (Foundation Year, Company Profile and etc.)

    • Table Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Product and Service

    • Table Boston Biomedical, Inc (Foundation Year, Company Profile and etc.)

    • Table Boston Biomedical, Inc Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boston Biomedical, Inc Gastrointestinal Stromal Tumor (GIST) Drug Product and Service

    • Table Calithera Biosciences, Inc (Foundation Year, Company Profile and etc.)

    • Table Calithera Biosciences, Inc Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Calithera Biosciences, Inc Gastrointestinal Stromal Tumor (GIST) Drug Product and Service

    • Table Deciphera Pharmaceuticals, LLC (Foundation Year, Company Profile and etc.)

    • Table Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Product and Service

    • Table Novartis AG (Foundation Year, Company Profile and etc.)

    • Table Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US